Doctor of Osteopathy Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Lon Lynn

Family Medicine Tampa, FL Doctor of Osteopathy

NPI 1497898282 CMS profile 204601

3910 Northdale Blvd Ste 206, Tampa, FL 33624

Open in the dashboard

General payments

$12,753

219 records reported · program years 2019–2024

Research payments

$14,076

Paid to them · 26 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$9,655,367 paid to institutions, not to them · program years 2019–2025

Through program year 2024, Lon Lynn of Tampa, FL is reported in the CMS Open Payments database as having received $12,753 across 219 general payments and $14,076 in research payments paid to them. Separately, studies naming them as principal investigator received $9,655,367 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $2,742 24
2024 Research $1,402 10
2023 General $770 4
2023 Research $1,734 2
2022 General $318 13
2022 Research $7,938 2
2021 General $1,059 59
2021 Research $1,794 3
2020 General $4,241 60
2019 General $3,623 59
2019 Research $1,209 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lon Lynn
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Lon Lynn were reported at $0. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Lon Lynn Family Medicine median Middle half National median
2019 $3,623 $150 $41–$543 $163
2020 $4,241 $120 $32–$415 $114
2021 $1,059 $137 $35–$551 $132
2022 $318 $137 $37–$512 $149
2023 $770 $149 $42–$545 $160
2024 $2,742 $156 $44–$560 $164
2025 $0 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Amgen Inc. $3,763 20 payments
  2. Eli Lilly and Company $2,286 18 payments
  3. AstraZeneca Pharmaceuticals LP $2,079 40 payments
  4. Pacira Pharmaceuticals Incorporated $1,123 8 payments
  5. Novo Nordisk Inc $810 45 payments
  6. Novo Nordisk AS $650 3 payments
  7. Radius Health, Inc. $194 8 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $175 8 payments
  9. Sanofi-Aventis U.S. LLC $172 9 payments
  10. Amneal Pharmaceuticals LLC $153 9 payments
  11. Other $1,350 51 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $5,195 192 payments
  2. Travel and Lodging $4,307 21 payments
  3. Consulting Fee $3,200 2 payments
  4. Education $51 4 payments
Products named General payments · program years 2019–2024
  1. BEVESPI AEROSPHERE $1,532 4 payments
  2. Zilretta $1,123 8 payments
  3. Tresiba $728 10 payments
  4. Ozempic $667 35 payments
  5. Prolia $465 13 payments
  6. RYBELSUS $450 27 payments
  7. FARXIGA $420 26 payments
  8. EVENITY $241 12 payments
  9. Tymlos $194 8 payments
  10. JARDIANCE $175 8 payments
  11. Other $2,414 119 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Eli Lilly and Company $11,466 7 payments
  2. Regeneron Pharmaceuticals, Inc. $1,402 10 payments
  3. GlaxoSmithKline, LLC. $1,209 9 payments

Records

245 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record